I am hoping UCM has one of the better ratios of profit as opposed to market cap on the entire ASX come July (which would make an overall profitable FY20 which is incredible for a company with a market cap just above $30 million and in the med tech arena)
And presume Meng may feel the same due to not even realistically needing to top up at these levels due to his massive holding already, but did
And then with the other devices and approvals coming to light throughout the rest of 2020 and helping add to the sales network, should just keep building an extremely solid foundation from here on out
I missed buying ALU at $5 back in the day and there were holders there who had been holding from in the 20-30c range
If UCM can keep building on sales and products to sell and get a strong foothold in China and the U.S, I think this can be the opportunity I don’t let pass me by this time round
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable